Related Experiment Video
Updated: Dec 30, 2025

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Roles of circRNAs in the tumour microenvironment.
Qiuge Zhang1,2, Weiwei Wang3, Quanbo Zhou4
1Department of Geriatric Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Circular RNAs (circRNAs) regulate the tumor microenvironment (TME) by influencing immune surveillance, angiogenesis, and therapy resistance. Targeting circRNAs offers a promising strategy for cancer treatment and biomarker development.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- The tumor microenvironment (TME) is crucial in cancer progression and metastasis.
- Circular RNAs (circRNAs) are key regulators of gene expression with diverse roles in cancer.
- The specific mechanisms by which circRNAs influence the TME are not fully understood.
Purpose of the Study:
- To review the multifaceted roles of circRNAs in regulating the tumor microenvironment (TME).
- To explore the impact of circRNAs on key TME processes like immune surveillance and angiogenesis.
- To highlight the therapeutic potential of circRNAs in cancer treatment.
Main Methods:
- Literature review and analysis of existing studies on circRNAs and the TME.
- Synthesis of current knowledge on circRNA functions within the TME.
- Discussion of circRNAs' roles in immune evasion, angiogenesis, hypoxia, and matrix remodeling.
Main Results:
- CircRNAs significantly modulate immune surveillance, angiogenesis, hypoxia, and matrix remodeling within the TME.
- Exosomal circRNAs (exo-circRNAs) play a role in intercellular communication within the TME.
- CircRNAs are implicated in resistance to chemoradiation therapies.
Conclusions:
- CircRNAs are critical regulators of the tumor microenvironment (TME) with diverse functions.
- Targeting circRNAs presents a novel therapeutic strategy to overcome cancer resistance.
- CircRNAs hold potential as noninvasive biomarkers for cancer diagnosis and prognosis.
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

